| Primary |
| Benign Prostatic Hyperplasia |
31.9% |
| Insomnia |
13.8% |
| Depression |
11.7% |
| Dysuria |
4.8% |
| Prostate Cancer |
4.8% |
| Constipation |
4.3% |
| Bronchopulmonary Aspergillosis |
3.2% |
| Gastrointestinal Motility Disorder |
3.2% |
| Parkinson's Disease |
3.2% |
| Right Ventricular Failure |
3.2% |
| Tremor |
2.7% |
| Orthostatic Hypotension |
2.1% |
| Pollakiuria |
2.1% |
| Asthma |
1.6% |
| Immunosuppressant Drug Therapy |
1.6% |
| Reflux Oesophagitis |
1.6% |
| Cerebral Infarction |
1.1% |
| Diabetes Mellitus |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Hypertension |
1.1% |
|
| Anaemia |
10.6% |
| Hepatitis Fulminant |
10.6% |
| Confusional State |
6.4% |
| Syncope |
6.4% |
| Cardiac Failure |
4.3% |
| Dermatomyositis |
4.3% |
| Drug Eruption |
4.3% |
| Eye Operation |
4.3% |
| Floppy Iris Syndrome |
4.3% |
| Gynaecomastia |
4.3% |
| Intraocular Pressure Increased |
4.3% |
| Iris Disorder |
4.3% |
| Loss Of Consciousness |
4.3% |
| Neuroleptic Malignant Syndrome |
4.3% |
| Orthostatic Hypotension |
4.3% |
| Pneumonia Aspiration |
4.3% |
| Polymyositis |
4.3% |
| Renal Disorder |
4.3% |
| Urinary Retention |
4.3% |
| Aphasia |
2.1% |
|
| Secondary |
| Benign Prostatic Hyperplasia |
28.6% |
| Drug Use For Unknown Indication |
17.7% |
| Hypertension |
8.2% |
| Insomnia |
8.2% |
| Depression |
7.8% |
| Rheumatoid Arthritis |
5.2% |
| Dysuria |
3.5% |
| Spinal Cord Disorder |
3.5% |
| Product Used For Unknown Indication |
2.2% |
| Cardiac Failure |
1.7% |
| Constipation |
1.7% |
| Hyperuricaemia |
1.7% |
| Parkinson's Disease |
1.7% |
| Pollakiuria |
1.7% |
| Prostate Cancer |
1.7% |
| Ill-defined Disorder |
1.3% |
| Cardiac Failure Chronic |
0.9% |
| Gastritis |
0.9% |
| Hyperlipidaemia |
0.9% |
| Hypertonic Bladder |
0.9% |
|
| Drug Eruption |
15.4% |
| Interstitial Lung Disease |
9.6% |
| Rash Papular |
7.7% |
| Stevens-johnson Syndrome |
7.7% |
| Urinary Retention |
7.7% |
| Hepatitis Fulminant |
5.8% |
| Loss Of Consciousness |
5.8% |
| Pyrexia |
5.8% |
| Dyspnoea |
3.8% |
| Erythema |
3.8% |
| Floppy Iris Syndrome |
3.8% |
| Hypothermia |
3.8% |
| Liver Disorder |
3.8% |
| Pneumonia Aspiration |
3.8% |
| Ageusia |
1.9% |
| Aphasia |
1.9% |
| Blood Amylase Increased |
1.9% |
| Concomitant Disease Progression |
1.9% |
| Dermatomyositis |
1.9% |
| Dizziness |
1.9% |
|
| Concomitant |
| Benign Prostatic Hyperplasia |
17.1% |
| Hypertension |
14.6% |
| Drug Use For Unknown Indication |
12.4% |
| Prophylaxis |
7.9% |
| Prostate Cancer |
5.4% |
| Constipation |
5.2% |
| Insomnia |
3.9% |
| Gastritis |
3.3% |
| Prostate Cancer Stage Iv |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Diabetes Mellitus |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Asthma |
2.6% |
| Dysuria |
2.5% |
| Pain |
2.4% |
| Renal Cell Carcinoma |
2.1% |
| Cerebral Infarction |
2.1% |
| Chronic Hepatitis C |
2.1% |
| Gastric Ulcer |
2.1% |
| Parkinson's Disease |
2.0% |
|
| Interstitial Lung Disease |
12.3% |
| White Blood Cell Count Decreased |
10.2% |
| Hypoglycaemia |
8.1% |
| Pneumonia |
7.4% |
| Pyrexia |
6.3% |
| Platelet Count Decreased |
5.6% |
| Prostate Cancer |
5.6% |
| Urinary Retention |
5.3% |
| Vomiting |
5.3% |
| White Blood Cell Count Increased |
5.3% |
| Renal Impairment |
4.6% |
| Cerebral Haemorrhage |
3.9% |
| Thrombocytopenia |
3.5% |
| Sepsis |
2.8% |
| Death |
2.5% |
| Delirium |
2.5% |
| Pleural Effusion |
2.5% |
| Renal Cell Carcinoma |
2.5% |
| Erythema Multiforme |
2.1% |
| Pneumothorax |
2.1% |
|
